I recently attended the second Ending Age-Related Diseases conference in New York, hosted by the Life Extension Advocacy Foundation (LEAF). The mix of attendees was much the same as last year: an even split between scientists, entrepreneurs, investors, patient advocates, and interested onlookers, all focused on the treatment of aging as a medical condition. The presentations were similarly a mix of scientists talking about their research programs, entrepreneurs presenting on the data produced by their companies, and investors discussing the state of the industry. For my part, I have already presented several times this year on the work taking place at Repair Biotechnologies, while we were raising our seed round. So rather talk again on a familiar topic, I chose instead to discuss the terrible state
From https://aubreyflores.blogspot.com/2019/07/notes-on-2019-ending-age-related.html
From https://christinowlin.blogspot.com/2019/07/notes-on-2019-ending-age-related.html
from
https://christinowlin.wordpress.com/2019/07/18/notes-on-the-2019-ending-age-related-diseases-conference-in-new-york/
No comments:
Post a Comment